2022 AOSSM Annual Meeting Recordings with CME-The Business of OrthoBiologics in Clinical Practice

The Business of OrthoBiologics in Clinical Practice

Video Transcription

Video Summary

In this video, the speaker discusses the cost and effectiveness of orthobiologic treatments, specifically focusing on platelet-rich plasma (PRP) therapy and cell therapy. They mention that commercial insurance generally does not cover orthobiologics and highlight the aggressive marketing and allure of these treatments. The speaker emphasizes that current treatments for certain conditions are imperfect and variable in outcomes. They also discuss the cost variability of PRP therapy and cite studies on its cost-effectiveness compared to other options. The speaker concludes by emphasizing the need for realistic patient expectations, responsible use of therapies, and a rigorous evidence-based approach in this field. No credits were mentioned.

Asset Caption

Scott Rodeo, MD

Keywords

orthobiologic treatments

platelet-rich plasma therapy

cell therapy

commercial insurance coverage

cost-effectiveness